Company Profile:
IGENOMIX FZ LLC Company Profile
IGENOMIX FZ LLC is a company that specializes in advanced reproductive genetics. They are primarily known for their innovative genetic testing services that help improve the success rates of assisted reproductive technologies (ART). Their services include Preimplantation Genetic Testing (PGT) for aneuploidies (PGT-A), monogenic diseases (PGT-M), and structural chromosomal rearrangements (PGT-SR), as well as endometrial receptivity analysis (ERA) and non-invasive prenatal testing (NIPT).
Based on the nature of their operations, IGENOMIX FZ LLC is best categorized as a **service provider** in the medical and biotechnology sector, rather than a factory or a pure trader. They develop and perform specialized genetic tests, which involves significant scientific research, laboratory work, and expert analysis. While they offer their services to clients (clinics and patients), they are not manufacturing physical goods in the traditional sense of a factory, nor are they simply buying and selling existing products like a trading company. Their core business revolves around the intellectual property and specialized procedures involved in genetic diagnostics.
Enterprise Products
IGENOMIX FZ LLC in the UAE offers and sells the following products:
* **Genetic Compatibility Test (GCT):** To reduce the risk of having offspring with genetic diseases.
* **Preimplantation Genetic Testing for Aneuploidy (PGT-A):** To screen embryos for chromosomal abnormalities before implantation.
* **Preimplantation Genetic Testing for Monogenic Diseases (PGT-M):** To screen embryos for specific single-gene disorders.
* **Preimplantation Genetic Testing for Structural Rearrangements (PGT-SR):** To screen embryos for structural chromosomal rearrangements.
* **Non-Invasive Prenatal Testing (NIPT):** A screening test performed on the pregnant woman's blood to detect common chromosomal abnormalities in the fetus.
* **Carrier Genetic Test (CGT):** To determine if individuals are carriers for certain genetic diseases.
* **Endometrial Receptivity Analysis (ERA):** To assess the optimal time for embryo transfer.
* **Endometrial Microbiome Analysis (EMMA):** To analyze the endometrial microbiome.
* **Infectious Disease Screening (ID Screen):** To screen for infectious diseases.
* **Pharmacogenetic Testing:** To determine how a person's genes affect their response to medications.